,ATI NR 293 PHARM
FINAL REVIEW EXAM
QUESTIONS AND
ANSWERS VERIFIED &
LATEST UPDATE 2025
,a) Decrease chest wall compliance
b) Suppress respiratory effort
i) Rationale: Neuromuscular blocking agents, such as pancuronium, induce
paralysis and suppress the client's respiratory efforts to the point of
, apnea, allowing the mechanical ventilator to take over the work of
breathing for the client. This therapy is especially
helpful for a client who has ARDS and poor lung
compliance.
c) Induce sedation
d) Decrease respiratory secretions
• A nurse is caring for a client who is taking lisinopril. Which of the following
outcomes indicates a therapeutic effect of the medication? a) Decreased blood
pressure
i) Rationale: Lisinopril, an ACE inhibitor, may be used alone or in
combination with other antihypertensives in the management of
hypertension and congestive heart failure. A therapeutic effect of the
medication is a decrease in blood pressure.
b) Increase of HDL cholesterol
i) Rationale: This is not an intended effect of lisinopril.
FINAL REVIEW EXAM
QUESTIONS AND
ANSWERS VERIFIED &
LATEST UPDATE 2025
,a) Decrease chest wall compliance
b) Suppress respiratory effort
i) Rationale: Neuromuscular blocking agents, such as pancuronium, induce
paralysis and suppress the client's respiratory efforts to the point of
, apnea, allowing the mechanical ventilator to take over the work of
breathing for the client. This therapy is especially
helpful for a client who has ARDS and poor lung
compliance.
c) Induce sedation
d) Decrease respiratory secretions
• A nurse is caring for a client who is taking lisinopril. Which of the following
outcomes indicates a therapeutic effect of the medication? a) Decreased blood
pressure
i) Rationale: Lisinopril, an ACE inhibitor, may be used alone or in
combination with other antihypertensives in the management of
hypertension and congestive heart failure. A therapeutic effect of the
medication is a decrease in blood pressure.
b) Increase of HDL cholesterol
i) Rationale: This is not an intended effect of lisinopril.
